EFDID: 561349EFD: View Filing

Issuer: Armis Biopharma, Inc. (0001604801) - D

Accession: 0001604801-25-000003 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001604801
  • Entity Name:
    Armis Biopharma, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    2401 RESEARCH BLVD, SUITE 205
    FORT COLLINS, CO 80526
  • Persons:
    Related Persons 8
    Theodore Ziemann
    Director
    Steve Coder
    Executive Officer, Director
    Alan Ruud
    Director
    Alan Smith, Ph.D.
    Director
    Christopher Rudd
    Director
    Michael Voss
    Executive Officer, Director
    Michael Litwack
    Director
    William Nelson, MD, Ph.D.
    Director
EDGAR: Offering Information
  • Accession Date:
    07/10/2025
  • First Sale Date:
    06/27/2025
  • Offering Amount:
    $3,000,000
  • Amount Sold:
    $1,000,000
  • Amount Remaining:
    $2,000,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Armis Biopharma, Inc./s/ Steve CoderSteve CoderChief Financial Officer2025-07-10